Signature Resources Capital Management, LLC
Position in LLY — ELI LILLY & Co
CIK 1940917
NEWPORT BEACH, CA
Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$20,390
+$5,674 QoQ
Shares Held
17
+6.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#4,564
of 4,605 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Signature Resources Capital Management, LLC holds $722,254 across 10 Drug Manufacturers - General names. LLY ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
838 | $210,874 | |
| 2 | JNJ |
Johnson & Johnson
|
801 | $203,429 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,570 | $201,745 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
260 | $32,848 | |
| 5 | AMGN |
Amgen Inc
|
87 | $31,504 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
17 | $20,390 | |
| 7 | PFE |
Pfizer Inc
|
373 | $8,981 | |
| 8 | NVS |
Novartis AG
|
45 | $7,052 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,390 | 17 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $14,716 | 16 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $16,120 | 15 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $9,156 | 12 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $9,354 | 12 | Shares | Sole | 2025-07-16 | |
| 2024-06-30 | $9,053 | 10 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $7,779 | 10 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $5,829 | 10 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||